Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Convalescent plasma vs best supportive care in severe COVID-19
2020-001310-38Phase 2Recruiting
- Sponsor
- DRK-Blutspendedienst Baden-Württemberg-Hessen
- Start
- Mar 2020
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in coronavirus disease 2019 (COVID-19) and viral pneumonia comparing Convalescent plasma + best supportive care with Best supportive care alone (2 arms). Primary endpoint: Composite primary endpoint. Started Mar 2020; status: recruiting.
02
Drugs
convalescent plasma (Heinrich-Heine University, Duesseldorf)
03
Conditions
coronavirus disease 2019 (COVID-19)viral pneumonia
Beyond the preview
Go deeper on 2020-001310-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001310-38.